Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1975 Apr;11(2):105-11.
doi: 10.1007/BF00429832.

Antifibrin action of phenformin

R N Banerjee, V Kumar, S R Rao, A L Sahni, M Arya, J Bardhan

Antifibrin action of phenformin

R N Banerjee et al. Diabetologia. 1975 Apr.

Abstract

Effects of phenformin on blood sugar, serum triglyceride, thrombin time, euglobulin clot lysis time and cardiovascular complications were studied in maturity onset diabetes and in atherosclerotic patients with or without diabetes, for a period of 14-18 months. Phenformin has shown the characteristic properties of an antifibrinopathic agent in that it prolongs thrombin time and enhances fibrinolysis. The hypoglycaemic effect of phenformin was found to be directly related to its antifibrinopathic action. Plasma lipids fell in all cases. Absence of fresh cardiovascular complications and improvement in anginal symptoms were observed. The metabolic, haematological and clinical benefits of phenformin and its limitations in maturity onset diabetes and atherosclerosis may be explained by the effects of the drug upon the thrombin-fibrinogen reaction. These results lend support to the hypothesis of a primary fibrinopathic pathogenesis in maturity onset diabetes mellitus and atherosclerosis.

PubMed Disclaimer

References

    1. Scand J Haematol. 1970;7(5):404-8 - PubMed
    1. Br Med J. 1961 Jun 24;1(5242):1796-9 - PubMed
    1. Br J Haematol. 1972 May;22(5):543-59 - PubMed
    1. Proc Soc Exp Biol Med. 1957 May;95(1):190-2 - PubMed
    1. Postgrad Med J. 1969 May;45:24-9 - PubMed